| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP, Chief Legal Officer | EVP, General Counsel
1 company
Davis George Eric is an EVP, Chief Legal Officer at BMRN. Recent filings cover 0 purchases and 38 sales. Those positions are worth an estimated $4.0M at current prices.
Our model assigns Davis George Eric a middling insider score of 65/100, based on 13 past trades. Over a 12-month horizon, 58.3% of those trades were profitable, with an average 12-month return of +5.4%.
Davis George Eric's largest disclosed position is in BMRN as EVP, Chief Legal Officer, worth about $4.0M. The recent filings there lean toward selling, a net 345,212 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 21, 2022 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 6,129 | $81.29 | $498,226.41 | -8.8% | -3.4% | +13.5% | |
| Aug 2, 2021 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 5,518 | $76.69 | $423,175.42 | -8.6% | +6.0% | +12.0% | |
| May 3, 2021 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 4,673 | $78.30 | $365,895.90 | -6.8% | -1.6% | +6.2% | |
| Apr 19, 2021 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sale+OE | 2,709 | $79.58 | $215,582.22 | -3.8% | -1.0% | +1.2% | |
| May 1, 2020 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 12,504 | $89.38 | $1,117,607.52 | -16.0% | - | - | |
| Nov 26, 2019 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 3,190 | $79.66 | $254,115.40 | -4.4% | - | - | |
| Mar 25, 2019 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 3,363 | $87.86 | $295,473.18 | -4.5% | - | - | |
| Mar 19, 2019 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 7,907 | $93.92 | $742,625.44 | -9.1% | - | - | |
| Sep 14, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 2,216 | $99.45 | $220,385.90 | -3.0% | - | - | |
| Sep 13, 2018 | BMRN Biomarin Pharmaceutical Inc | EVP, General Counsel | Sell | 12,000 | $99.57 | $1,194,840.00 | -13.8% | - | - |